Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled phase 3 study of adjunctive pregabalin in infants and young children with partial seizures
MOH_2017-08-28_000763Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in epilepsy and Focal Onset Epilepsy (3 arms), sponsored by Pfizer. Primary endpoint: Reduction in frequency of partial seizures. Started Oct 2014; status: recruiting.
02
Drugs
pregabalin
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on MOH_2017-08-28_000763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-08-28_000763.